| Mycophenolic acid |
EU/1/96/005/001 |
CellCept, Capsule, hard, 250, mg, Pack: 100 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
194.14 |
38.83 |
232.97 |
6% |
11.65 |
205.79 |
41.16 |
246.95 |
18% |
30 |
235.79 |
47.16 |
282.95 |
|
КЦ-529/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
2332 |
| Mycophenolic acid |
EU/1/96/005/006 |
CellCept, Powder for oral suspension, 110, g, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
269.85 |
53.97 |
323.82 |
4% |
10 |
279.85 |
55.97 |
335.82 |
16% |
25 |
304.85 |
60.97 |
365.82 |
цената се заличава КЦРР-2334/21.02.2013 |
КЦРР-216/27.02.2012 |
13.03.2012 |
13.03.2012 |
Заличен |
1143 |
| Mycophenolic acid |
EU/1/96/005/006 |
CellCept, Powder for oral suspension, 110, g, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
271.82 |
54.36 |
326.18 |
6% |
15 |
286.82 |
57.36 |
344.18 |
18% |
30 |
316.82 |
63.36 |
380.18 |
|
КЦ-529/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
1143 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare BV, Нидерландия |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
Промяна на обстоятелства НСР-18153/07.03.2019 |
НСР-8333/26.02.2016; НСР-12479/28.04.2017 г.; НСР-15082/23.02.2018; НСР-17252/14.11.2018 |
29.11.2018 |
02.04.2019 |
Активен |
3473 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
|
НСР-8333/26.02.2016; НСР-12479/28.04.2017 г.; НСР-15082/23.02.2018; НСР-17252/14.11.2018 |
29.11.2018 |
02.12.2018 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare BV, Нидерландия |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
Промяна на обстоятелства НСР-18153/07.03.2019 |
НСР-8328/26.02.2016; НСР-12480/28.04.2017 г.; НСР-15083/23.02.2018; НСР-17254/14.11.2018 |
29.11.2018 |
02.04.2019 |
Активен |
3472 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1039.68 |
207.94 |
1247.62 |
4% |
10 |
1049.68 |
209.94 |
1259.62 |
16% |
25 |
1074.68 |
214.94 |
1289.62 |
|
НСР-8328/26.02.2016; НСР-12480/28.04.2017 г.; НСР-15083/23.02.2018; НСР-17254/14.11.2018 |
29.11.2018 |
02.12.2018 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1082.51 |
216.5 |
1299.01 |
4% |
10 |
1092.51 |
218.5 |
1311.01 |
16% |
25 |
1117.51 |
223.5 |
1341.01 |
|
НСР-8328/26.02.2016; НСР-12480/28.04.2017 г.; НСР-15083/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1082.51 |
216.5 |
1299.01 |
4% |
10 |
1092.51 |
218.5 |
1311.01 |
16% |
25 |
1117.51 |
223.5 |
1341.01 |
|
НСР-8333/26.02.2016; НСР-12479/28.04.2017 г.; НСР-15082/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1093.13 |
218.63 |
1311.76 |
4% |
10 |
1103.13 |
220.63 |
1323.76 |
16% |
25 |
1128.13 |
225.63 |
1353.76 |
|
НСР-8328/26.02.2016; НСР-12480/28.04.2017 г. |
13.05.2017 |
02.06.2017 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1093.13 |
218.63 |
1311.76 |
4% |
10 |
1103.13 |
220.63 |
1323.76 |
16% |
25 |
1128.13 |
225.63 |
1353.76 |
|
НСР-8333/26.02.2016; НСР-12479/28.04.2017 г. |
13.05.2017 |
02.06.2017 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1131.96 |
226.39 |
1358.35 |
4% |
10 |
1141.96 |
228.39 |
1370.35 |
16% |
25 |
1166.96 |
233.39 |
1400.35 |
|
НСР-8333/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1131.96 |
226.39 |
1358.35 |
4% |
10 |
1141.96 |
228.39 |
1370.35 |
16% |
25 |
1166.96 |
233.39 |
1400.35 |
|
НСР-8328/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutsch-land GmbH, Герма-ния |
1131.98 |
226.4 |
1358.38 |
4% |
10 |
1141.98 |
228.4 |
1370.38 |
16% |
25 |
1166.98 |
233.4 |
1400.38 |
|
НСР-5311/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutsch-land GmbH, Герма-ния |
1131.98 |
226.4 |
1358.38 |
4% |
10 |
1141.98 |
228.4 |
1370.38 |
16% |
25 |
1166.98 |
233.4 |
1400.38 |
|
НСР-5310/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1218.36 |
243.67 |
1462.03 |
4% |
10 |
1228.36 |
245.67 |
1474.03 |
16% |
25 |
1253.36 |
250.67 |
1504.03 |
|
НСР-3354/29.04.2014 |
13.05.2014 |
13.05.2014 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1218.36 |
243.67 |
1462.03 |
4% |
10 |
1228.36 |
245.67 |
1474.03 |
16% |
25 |
1253.36 |
250.67 |
1504.03 |
|
НСР-3380/29.04.2014 |
13.05.2014 |
13.05.2014 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1244.14 |
248.83 |
1492.97 |
4% |
10 |
1254.14 |
250.83 |
1504.97 |
16% |
25 |
1279.14 |
255.83 |
1534.97 |
|
НСР-1090/02.09.2013 |
18.09.2013 |
18.09.2013 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1244.14 |
248.83 |
1492.97 |
4% |
10 |
1254.14 |
250.83 |
1504.97 |
16% |
25 |
1279.14 |
255.83 |
1534.97 |
|
НСР-1090/02.09.2013 |
18.09.2013 |
18.09.2013 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1312.73 |
262.55 |
1575.28 |
4% |
10 |
1322.73 |
264.55 |
1587.28 |
16% |
25 |
1347.73 |
269.55 |
1617.28 |
промяна на обстоятелства решение КЦPP-2852/20.03.2013 |
КЦРР-2030/21.01.2013 |
03.04.2013 |
03.04.2013 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия |
1312.73 |
262.55 |
1575.28 |
4% |
10 |
1322.73 |
264.55 |
1587.28 |
16% |
25 |
1347.73 |
269.55 |
1617.28 |
промяна на обстоятелства решение КЦPP-2851/20.03.2013 |
КЦРР-2030/21.01.2013 |
03.04.2013 |
03.04.2013 |
Неактивен |
3472 |
| Maraviroc |
EU/1/07/418/008 |
Celsentri, Film coated tablet, 300, mg, Pack: 60 |
Pfizer Limited, Обединено Кралство |
Gödecke GmbH (a pharma plant of Pfizer GmbH), Германия |
1525.55 |
305.11 |
1830.66 |
4% |
10 |
1535.55 |
307.11 |
1842.66 |
16% |
25 |
1560.55 |
312.11 |
1872.66 |
|
КЦ-856/12.05.2009 |
29.05.2009 |
29.05.2009 |
Неактивен |
3473 |
| Maraviroc |
EU/1/07/418/003 |
Celsentri, Film coated tablet, 150, mg, Pack: 60 |
Pfizer Limited, Обединено Кралство |
Gödecke GmbH (a pharma plant of Pfizer GmbH), Германия |
1525.55 |
305.11 |
1830.66 |
4% |
10 |
1535.55 |
307.11 |
1842.66 |
16% |
25 |
1560.55 |
312.11 |
1872.66 |
|
КЦ-856/12.05.2009 |
29.05.2009 |
29.05.2009 |
Неактивен |
3472 |
| Quetiapine |
20090320 |
CENTROQUEEN, Film coated tablet, 100, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД, Пловдив, България |
6.06 |
1.21 |
7.27 |
7% |
0.42 |
6.48 |
1.3 |
7.78 |
20% |
1.21 |
7.69 |
1.54 |
9.23 |
Промяна на обстоятелства НСР-11913/06.03.2017 |
КЦ-1111/09.09.2009; НСР-17214/09.11.2018 |
24.11.2018 |
02.12.2018 |
Активен |
818 |
| Quetiapine |
20090320 |
CENTROQUEEN, Film coated tablet, 100, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайкафарма Висококачествените Лекарства" АД, Пловдив, България |
6.06 |
1.21 |
7.27 |
7% |
0.42 |
6.48 |
1.3 |
7.78 |
20% |
1.21 |
7.69 |
1.54 |
9.23 |
Промяна на обстоятелства НСР-11913/06.03.2017 |
КЦ-1111/09.09.2009; НСР-17214/09.11.2018 |
24.11.2018 |
02.12.2018 |
Неактивен |
818 |